Palvella Therapeutics paid its 3 named executives $7.4M in total in FY2025 (Dec). CEO Wesley H. Kaupinen was paid $3.4M of that.
Pay$100 in the stock at the end of FY22 → $126
Pay of each named executive
Wesley H. KaupinenPresident and Chief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Kathleen GoinChief Operating Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Matthew E. KorenbergChief Financial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.